Purchase Order 75N93025P01087
- Not listed
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order worth $35,916.00 to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The award, which was set aside for small businesses, is for the supply of 10X Genomics' Visium HD, Mouse Transcriptome, 6.5 mm product under a brand name restriction. This procurement was conducted using...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $422,158.65 firm fixed price purchase order to 10X Genomics, Inc. to obtain sequencing materials and reagents. The sole source award was made under a notice announcing NIH's intent to procure the materials and reagents from 10X Genomics to support sequencing and genomics analysis on equipment owned and optimized by NIH's Vaccine Research Center and Vaccine...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $16,106.50 firm fixed price purchase order to 10X Genomics, Inc., doing business as 10X Genomics, located in Pleasanton, California. The contract has a period of performance from September 25, 2023 through October 24, 2023. It carries a total small business set aside designation. As a leading life science technology company, 10X Genomics will provide its...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc., doing business as 10X Genomics, of Pleasanton, California. The contract has a period of performance from July 20, 2023 through September 4, 2023. This purchase order was set aside for total small business and will provide genomic products and services to support NIH research efforts aimed at...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $222,742 firm fixed price purchase order to 10X Genomics, Inc. for biological product manufacturing kits in support of ongoing studies at its Center for Human Immunology. The kits include Library Construction Kits, Chromium Next GEM Single Cell sequencing kits, Feature Barcode Kits, and Dual Index kits to maintain consistency and reproducibility for scientific results. Per the original...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,889.50 firm fixed price purchase order to 10X Genomics, Inc. for 10X Genomics Chromium Next Gem products. The place of performance will be 10X Genomics' facilities in Pleasanton, California, with work expected to be completed by February 14, 2024. As the National Institute of Allergy and Infectious Diseases conducts research on preventing, diagnosing and...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to 10X Genomics, Inc. for $110,998.56 to provide specialized kits for single cell RNA sequencing, single cell ATAC sequencing, single cell multi-omics, and spatial transcriptomics. This purchase order was issued under a total small business set-aside and is for the supply of 10X Genomics' brand name products,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc. for unspecified products or services in support of the agency's research programs. The contract has a period of performance from September 26, 2023 through October 25, 2023 and will be performed in Pleasanton, California. This sole source award was set aside for total small businesses. No additional...
- This is a $24,992.79 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of genomic analysis products. The contract is for the delivery of 10X Expression Kits, which support single-cell RNA sequencing, single-cell ATAC sequencing, multi-omics analysis, and spatial transcriptomics research. This contract is not set aside and...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to 10X Genomics, Inc. The contract has a ceiling value of $45,072.00 and is for the delivery of reagents to support ongoing clinical trials that began before January 20, 2025. The contract is not set aside and runs through June 30, 2025. 10X Genomics is a life sciences technology company that specializes in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $97,407.50 firm fixed-price purchase order to 10X Genomics, Inc. on September 29, 2025, for specialized reagents supporting spatial transcriptomic analysis of non-human primate lymph nodes. The contract, which has no set-aside designation, will be performed in Pleasanton, California, with an ultimate completion date of September 28, 2026. The procurement fulfills NIAID's Vaccine Research Center's Tissue Analysis Core requirement for advanced genomic analysis products, specifically 10X Genomics' proprietary microfluidic technology platforms, to characterize gene expression and immune signatures in lymph node tissues during SHIV infection. The reagent kits include gene expression analysis, single-cell analysis, indexing, and decoding products configured with a custom 301-480 gene panel designed to characterize non-human primate Fiebig stages and immune cell interactions. The solicitation was conducted under FAR Part 13 Simplified Acquisition Procedures as a sole-source procurement based on 10X Genomics' unique proprietary technology capabilities for simultaneous measurement of cell surface proteins, gene expression, and T-cell receptor detection. This acquisition supports NIAID's broader mission to discover and develop novel vaccines and biologics targeting infectious diseases of global public health importance. 10X Genomics has established itself as a key partner to federal biomedical research infrastructure through multiple contracts with NIH agencies, including a significant $7 million indefinite delivery contract with the National Institute on Aging that extends through July 2029.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
REAGENTS FOR SPATIAL TRANSCRIPTOMIC OF NHP FIEBIG IN LYMPH NODE | RFQ-NIAID-25-2270811 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 9/11/25, 9:30 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.4k | 9/26/25 |